3(S)-Formyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, 96%, 250mg

2,4-Difluorobenzylamine>98.0%(GC)5g

(E)-Methyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzoate, 98%, 100mg

(1-Methylethenyl)-benzene contains 15 ppm p-tert-butylcatechol as inhibitor, 95.0%, 100g

3-(((tert-Butoxycarbonyl)amino)methyl)-4-fluorobenzoic acid, 97%, 5g

2-Hydroxy-5-n-octanoylbenzoic Acid>98.0%(GC)(T)5g

Carboxy-PEG4-sulfonic acid, 500mg

Methyl 4-methyl-7-nitro-1H-indole-2-carboxylate, 95.0%, 250mg

Molybdenum foil 99.9+% 0.25 x 150 x 150 mm 1 pc

N-Methylmaleimide>98.0%(GC)25g

1,3-Dimethylthiourea>97.0%(T)25g

methyl 1-ethyl-3,6-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate, 250mg

(7-Chloro-3-methyl-4-oxo-6-((prop-2-ynyl(4-(pyridin-3-ylmethylcarbamoyl)phenyl)amino)methyl)-3,4-dihydroquinazolin-2-yl)methyl acetate, 98%, 25mg